« Previous
Next »
American Journal of Cardiology
Volume 102, Issue 1
, Pages 19-26
, 1 July 2008
Intravascular Ultrasound Assessment of Expansion of the Sirolimus-Eluting (Cypher Select) and Paclitaxel-Eluting (Taxus Express-2) Stent in Patients With Diabetes Mellitus
References
- The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol. 1998;32:584–589
- . Diabetes and coronary revascularization. JAMA. 2005;293:1501–1508
- . Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia (A serial intravascular ultrasound study). Circulation. 1997;95:1366–1369
- . Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol. 2005;45:1172–1179
- Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol. 2007;50:463–470
- Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions) substudy. Circulation. 2004;109:2273–2278
- Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the Diabetes and Sirolimus-Eluting Stent (DIABETES) trial. Circulation. 2005;112:2175–2183
- . Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients. Eur Heart J. 2007;28:1759–1764
- . Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls. Diab Vasc Dis Res. 2007;4:62–65
- . Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Circulation. 2003;108:1655–1661
- . Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation. 2004;109:867–873
- LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound study. Eur Heart J. 2005;26:2307–2312
- . Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol. 1998;81:1298–1304
- . Impaired compensatory coronary artery enlargement in atherosclerosis contributes to the development of coronary artery stenosis in diabetic patients (An in vivo intravascular ultrasound study). Eur Heart J. 1997;18:1090–1094
- Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. Am J Cardiol. 2005;96:74–78
- Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J. 2007;153:297–303
- Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation. 2004;109:1085–1088
- Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45:995–998
- Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol. 2004;43:1959–1963
- An intravascular ultrasound analysis of the mechanisms of restenosis comparing drug-eluting stents with brachytherapy. Am J Cardiol. 2006;97:1292–1298
- Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. Am J Cardiol. 2005;95:498–502
- . American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS) (A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents). J Am Coll Cardiol. 2001;37:1478–1492
- . Comparison of coronary stent expansion by intravascular ultrasonic imaging in younger versus older patients with diabetes mellitus. Am J Cardiol. 2000;85:559–562
- . Atherosclerosis in angiographically “normal” coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol. 1995;25:1479–1485
- . Arterial remodeling and coronary artery disease: the concept of “dilated” versus “obstructive” coronary atherosclerosis. J Am Coll Cardiol. 2001;38:297–306
- . Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol. 1998;32:1610–1618
- . Vessel size and long-term outcome after coronary stent placement. Circulation. 1998;98:1875–1880
- . Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol. 1998;32:1630–1635
- . Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. J Am Coll Cardiol. 1996;27:1678–1687
- . Mechanism of lumen gain during coronary stent deployment in diabetic patients compared with non-diabetic patients. Coron Artery Dis. 2002;13:263–268
- . Intravascular ultrasound findings in patients with restenosis of sirolimus- and paclitaxel-eluting stents. Int J Cardiol. 2008;125:11–15
PII: S0002-9149(08)00441-4
doi: 10.1016/j.amjcard.2008.02.093
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 102, Issue 1
, Pages 19-26
, 1 July 2008
